CanZx Biotherapeutics Overview

  • Founded
  • 2015
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $50K
Latest Deal Amount
  • Investors
  • 1

CanZx Biotherapeutics General Information


Developer of a cancer antibody designed to empower the immune system to fight cancer. The company's immunotherapeutic antibody boosts the immune system to fight cancer and also enhances response of tumors which are non-responsive to immunotherapies, enabling patients to improve their ability to fight cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Primary Office
  • 1531 North East 172nd Street
  • Shoreline, WA 98155
  • United States
+1 (206) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

CanZx Biotherapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 18-Jan-2017 $50K Completed Startup
1. Grant 01-Jan-2016 00000 Completed Startup
To view CanZx Biotherapeutics’s complete valuation and funding history, request access »

CanZx Biotherapeutics Executive Team (1)

Name Title Board Seat Contact Info
Jennifer Wu Ph.D Founder & President
To view CanZx Biotherapeutics’s complete executive team members history, request access »

CanZx Biotherapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

CanZx Biotherapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view CanZx Biotherapeutics’s complete investors history, request access »